Idarubicin Injection 20 mg/20 mL (3)

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

idarubicin hydrochloride, Quantity: 1 mg/mL

から入手可能:

Pfizer (Perth) Pty Ltd

医薬品形態:

Injection, solution

構図:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

投与経路:

Intravenous

パッケージ内のユニット:

1 x 20 mL

処方タイプ:

(S1) This Schedule is intentionally blank

適応症:

UK: Zavedos is used in adults and children for the treatment of acute non lymphoblastic leukaemia (ANLL), also referred to as acute myeloid leukaemia (AML). Zavedos is also used in adults and children as a second line treatment of relapsed acute lymphoblastic leukaemia (ALL)

製品概要:

Visual Identification: Red - orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

認証ステータス:

Listed (Export Only)

承認日:

2023-02-17